InfasurfAero™ for treating respiratory distress in preterm newborns
Official title: InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS: A Single-dose, Double-blind, Random Allocation, Sham-control, Clinical Trial
Run by Ony · NCT05960929 · Data updated 2026-11-12
This study is testing a new device that delivers a treatment for breathing problems in preterm newborns to see if it helps them breathe better without needing a breathing tube.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 29 Weeks to 36 Weeks |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | Ony Industry-sponsored |
| Locations | 10 sites (Phoenix, Arizona and 9 other locations) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | January 1, 2026 |
| Study ends | April 1, 2026 |
| Registry record updated | March 30, 2025 |
| Trial ID | NCT05960929 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are preterm newborns aged between 1 to 6 hours, with a gestational age of 29 to 35 weeks and diagnosed with surfactant-deficient RDS.
✕Probably not a fit
Patients who have received surfactant treatment or mechanical ventilation prior to randomization will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness and safety of Infasurf® delivered through the InfasurfAero™, a novel device designed for non-invasive administration without the need for intubation. The study involves a double-blind, randomized, sham-controlled design, where preterm newborns with respiratory distress syndrome (RDS) will receive either Infasurf or a sham treatment. The primary objectives are to assess the prevention of CPAP failure and the safety of the treatment. Participants will be recruited from multiple sites, with a focus on those who are stable on non-invasive respiratory support.
Why it matters
Potential benefit: If successful, this treatment could significantly improve respiratory support for preterm newborns with RDS, reducing the need for invasive procedures.
How similar studies have gone: Other studies have shown promise with similar non-invasive approaches for treating RDS, indicating potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Inclusion criteria include ALL of the following: 1. Written informed consent obtained by parent or legal representative prior to or after birth 2. Gestational age at birth ≥ 29 0/7 AND ≤ 35 6/7 weeks 3. Birthweight ≥ 1,000 AND ≤ 3,500 grams 4. Age ≥ 1 hour AND ≤ 6 hours 5. Clinical diagnosis of surfactant-deficient RDS, with EITHER i. a Silverman-Anderson Retraction Score ≥ 5 (in Room Air), OR ii. signs of respiratory distress (tachypnea, retractions, grunting) AND radiographic confirmation 6. Require CPAP 7. Respiratory Severity Score (RSS) ≥ 1.25 AND ≤ 2.4 8. If subject is \>346/7 weeks' gestation a chest radiograph is required Exclusion Criteria: Exclusion criteria are ANY of the following: 1. Surfactant administration prior to randomization 2. Mechanical ventilation prior to randomization 3. Major congenital anomaly (suspected or confirmed) 4. Abnormality of the airway (suspected or confirmed) 5. Respiratory distress presumed secondary to an etiology other than RDS (e.g., suspected pulmonary hypoplasia, pneumothorax, meconium aspiration syndrome, pneumonia, septic or hypovolemia shock, hypoxic ischemic encephalopathy) 6. Apgar score \< 3 at 5 minutes of age 7. Umbilical cord gas pH \<7.0 or BD \> 10 8. Any condition that, in the opinion of the Investigator, would place the neonate at undue risk
Where it's running
-
St. Josephs Hospital and Medical Center
Phoenix, Arizona, United States Recruiting -
Phoenix Children's
Phoenix, Arizona, United States Recruiting -
Sharp Mary Birch Hospital for Women & Newborns
San Diego, California, United States Recruiting -
University of Florida -Jacksonville
Jacksonville, Florida, United States Recruiting -
Kapi'olani Medical Center for Women & Children
Honolulu, Hawaii, United States Recruiting -
Jersey Shore University Medical Center
Neptune City, New Jersey, United States Recruiting
Show 4 more locations
-
Sisters of Charity Hospital
Buffalo, New York, United States Recruiting -
Western TN- Jackson-Madison County General Hospital
Jackson, Tennessee, United States Recruiting -
Utah Valley Hospital
Provo, Utah, United States Recruiting -
Unity Point Meriter
Madison, Wisconsin, United States Recruiting
Study contacts
- Study coordinator: Corey Commaroto, RRT
- Email: ccommaroto@onybiotech.com
- Phone: 7163614659
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How Different Levels of CPAP Deliver Oxygen to Preterm Babies
This study tests how much oxygen actually reaches preterm infants when they receive nasal CPAP at different air pressures.
-
Reference intervals for newborn brain biomarkers
Measure levels of brain-specific blood proteins (such as GFAP and Tau) in healthy full-term newborns during their first week of life to create normal reference ranges.
-
Surfactant delivery methods in preterm infants with RDS in Sweden
This study tests different ways of giving surfactant to preterm babies with respiratory distress to see which method works best when care is routine.
-
Video-guided vs direct laryngoscopy for less invasive surfactant delivery in extremely preterm infants
This trial tests whether using video laryngoscopy helps give surfactant on the first try more often than direct laryngoscopy in extremely preterm babies needing surfactant.
-
Mindfulness and meditation lactation education for mothers of premature NICU infants
This will test whether mindfulness and meditation training for mothers who are pumping for their premature NICU infants changes components of their breastmilk.
-
Lung volume changes with synchronized noninvasive ventilator support in preterm infants
This study will use a noninvasive imaging belt to see if synchronized ventilator inflations produce larger lung volumes than unsynchronized or backup inflations in very preterm infants on sNIPPV.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.